Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.32 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.32 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.32 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.32 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.32 |
| ▸ | ANPEP | P15144 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1086279 | 0.77 | CYP2C9 (0.39) | CYP2C9CYP2C19TDP1 | |
| SCHEMBL9280222 | 0.76 | CYP2C9 (0.41) | CYP2C9CYP2C19TDP1 | |
| SCHEMBL2422624 | 0.76 | — | — | |
| SCHEMBL28079774 | 0.75 | GGT1 (0.30) | — | |
| SCHEMBL10442053 | 0.75 | PLA2G1B (0.34) | CYP2C9CYP2C19TDP1 | |
| SCHEMBL10439956 | 0.75 | — | — | |
| SCHEMBL4940142 | 0.74 | HTR2A (0.34) | CYP2C9CYP2C19TDP1PRMT3CARM1 | |
| SCHEMBL9125572 | 0.72 | — | — | |
| SCHEMBL3817275 | 0.72 | CA12 (0.38) | CYP2C9CYP2C19TDP1ANPEP | |
| SCHEMBL7206010 | 0.71 | DPP7 (0.39) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8496716-B2 | Method for producing Mannich adducts that contain polyisobutylene phenol | BASF SE (DE) | 2013-07-30 | — | — | US | disclosed |
| US-20110251114-A1 | METHOD FOR PRODUCING MANNICH ADDUCTS THAT CONTAIN POLYISOBUTYLENE PHENOL | BASF SE (DE) | 2011-10-13 | — | — | US | disclosed |
| US-8016898-B1 | Method for producing Mannich adducts that contain polyisobutylene phenol | BASF AKTIENGESELLSCHAFT (DE) | 2011-09-13 | — | — | US | disclosed |
| US-7988749-B2 | Method for producing Mannich adducts that contain polyisobutylene phenol | BASF SE (DE) | 2011-08-02 | — | — | US | disclosed |
| US-20080274924-A1 | Alkylation of a phenol with polyisobutylene at low temperature in presence of alkylation catalyst; then formaldehyde and amine; oil and fuel additive | BASF AKTIENGESELLSCHAFT (DE) | 2008-11-06 | — | — | US | disclosed |
| US-20050268539-A1 | Additive mixture for fuel and lubricants | BASF AKTIENGESELLSCHAFT (DE) | 2005-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110251114-A1 | METHOD FOR PRODUCING MANNICH ADDUCTS THAT CONTAIN POLYISOBUTYLENE PHENOL | ADH1C, FANCF, PCNA | CYP2C9 2347/4885CYP2C19 2247/4885TDP1 1045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.